ATE288265T1 - Zusammensetzung zur linderung von störungen der stimmungslage bei gesunden individuen - Google Patents

Zusammensetzung zur linderung von störungen der stimmungslage bei gesunden individuen

Info

Publication number
ATE288265T1
ATE288265T1 AT98929625T AT98929625T ATE288265T1 AT E288265 T1 ATE288265 T1 AT E288265T1 AT 98929625 T AT98929625 T AT 98929625T AT 98929625 T AT98929625 T AT 98929625T AT E288265 T1 ATE288265 T1 AT E288265T1
Authority
AT
Austria
Prior art keywords
mood disorders
composition
healthy individuals
relieving mood
relieving
Prior art date
Application number
AT98929625T
Other languages
English (en)
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of ATE288265T1 publication Critical patent/ATE288265T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
AT98929625T 1997-06-18 1998-06-12 Zusammensetzung zur linderung von störungen der stimmungslage bei gesunden individuen ATE288265T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97RM000365A IT1291930B1 (it) 1997-06-18 1997-06-18 Composizione riequilibratrice delle turbe dell'umore in individui sani
PCT/IT1998/000157 WO1998057629A1 (en) 1997-06-18 1998-06-12 Composition for controlling mood disorders in healthy individuals

Publications (1)

Publication Number Publication Date
ATE288265T1 true ATE288265T1 (de) 2005-02-15

Family

ID=11405131

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98929625T ATE288265T1 (de) 1997-06-18 1998-06-12 Zusammensetzung zur linderung von störungen der stimmungslage bei gesunden individuen

Country Status (13)

Country Link
US (1) US6335021B1 (de)
EP (1) EP1001760B1 (de)
JP (1) JP2002505681A (de)
KR (1) KR20010013887A (de)
AT (1) ATE288265T1 (de)
AU (1) AU7930498A (de)
CA (1) CA2294589A1 (de)
DE (1) DE69828881T2 (de)
DK (1) DK1001760T3 (de)
ES (1) ES2236910T3 (de)
IT (1) IT1291930B1 (de)
PT (1) PT1001760E (de)
WO (1) WO1998057629A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2806307B1 (fr) * 2000-03-20 2002-11-15 Mane Fils V Preparation parfumee solide sous forme de microbilles et utilisation de ladite preparation
US6685674B2 (en) * 2001-03-04 2004-02-03 Sterling Medivations, Inc. Infusion hub assembly and fluid line disconnect system
DK1399143T3 (da) * 2001-05-29 2007-03-26 Sigma Tau Ind Farmaceuti Anvendelsen af Acetyl L-carnitin til fremstilling af et lægemiddel til behandling af anhedoni
US7407778B2 (en) * 2002-02-07 2008-08-05 Pettegrew Jay W Compounds, compositions and methods for treating neuropsychiatric disorders
US7700074B2 (en) * 2002-02-07 2010-04-20 Pettegrew Jay W Method and system for diagnosis of neuropsychiatric disorders including chronic alcoholism
US20050272812A1 (en) * 2002-02-07 2005-12-08 Pettegrew Jay W Methor for use of acetyl-L-carnitine (ALCAR) for treatment of depressive disorders in humans
US20040071681A1 (en) * 2002-10-10 2004-04-15 Lydia Muller Method and composition for reducing cravings for a craved substance
ATE437884T1 (de) * 2003-05-29 2009-08-15 Jay W Pettegrew Glycerophosphocholin und derivate davon zur medizinischen abbildung von neuropsychiatrischen erkrankungen
US20060257842A1 (en) * 2003-05-29 2006-11-16 Pettegrew Jay W Cryopreservation media and molecules
US8173618B2 (en) * 2003-07-25 2012-05-08 University Of Massachusetts Formulations for reducing neuronal degeneration
JP2006137746A (ja) * 2004-10-13 2006-06-01 Otsuka Pharmaceut Factory Inc オレキシン誘導組成物
WO2007011839A2 (en) * 2005-07-15 2007-01-25 Agilis Systems, Inc. Mobile resource location-based customer contact systems and methods
US7927787B2 (en) * 2006-06-28 2011-04-19 The Invention Science Fund I, Llc Methods and systems for analysis of nutraceutical associated components
US20070136092A1 (en) * 2005-11-30 2007-06-14 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging
US20080052114A1 (en) * 2005-11-30 2008-02-28 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems and methods related to nutraceuticals
US20070124219A1 (en) * 2005-11-30 2007-05-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized nutraceutical selection and packaging
US20110145009A1 (en) * 2005-11-30 2011-06-16 Jung Edward K Y Methods and systems related to transmission of nutraceutical associatd information
US10296720B2 (en) * 2005-11-30 2019-05-21 Gearbox Llc Computational systems and methods related to nutraceuticals
US7827042B2 (en) * 2005-11-30 2010-11-02 The Invention Science Fund I, Inc Methods and systems related to transmission of nutraceutical associated information
US8340944B2 (en) * 2005-11-30 2012-12-25 The Invention Science Fund I, Llc Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US20080004905A1 (en) * 2006-06-28 2008-01-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for analysis of nutraceutical associated components
US20070289258A1 (en) * 2006-06-14 2007-12-20 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Individualized pharmaceutical selection and packaging
US20080114577A1 (en) * 2005-11-30 2008-05-15 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational methods and systems associated with nutraceutical related assays
US8000981B2 (en) 2005-11-30 2011-08-16 The Invention Science Fund I, Llc Methods and systems related to receiving nutraceutical associated information
US20080103746A1 (en) * 2005-11-30 2008-05-01 Searete Llc, A Limited Liability Corporation Systems and methods for pathogen detection and response
US8297028B2 (en) 2006-06-14 2012-10-30 The Invention Science Fund I, Llc Individualized pharmaceutical selection and packaging
US20070124176A1 (en) * 2005-11-30 2007-05-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US7974856B2 (en) 2005-11-30 2011-07-05 The Invention Science Fund I, Llc Computational systems and methods related to nutraceuticals
US20080033763A1 (en) * 2005-11-30 2008-02-07 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems related to receiving nutraceutical associated information
US8597640B2 (en) * 2007-10-31 2013-12-03 University Of Massachusetts Lowell Over-the-counter vitamin/nutriceutical formulation that provides neuroprotection and maintains or improves cognitive performance in alzheimer's disease and normal aging
SG185692A1 (en) 2010-06-16 2013-01-30 Sigma Tau Ind Farmaceuti Acetyl-carnitine for use in a method for increasing neurogenesis in neural tissue
EP4149437A1 (de) 2020-05-15 2023-03-22 Alfasigma S.p.A. Zusammensetzung mit methylfolat

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0340759A1 (de) 1988-05-06 1989-11-08 MAGIS FARMACEUTICI S.p.A. Salze von O-Mono(di)-acetyl-glycero-mono-(bis)-(di)-Phosphaten von L-Acetylcarnitin und von L-Acetylcarnitin-Estern
JP3942207B2 (ja) * 1995-02-17 2007-07-11 武田薬品工業株式会社 うつ性症状改善剤
US5977162A (en) * 1996-09-16 1999-11-02 Seidman; Michael D. Therapeutic treatment for auditory function
US6066664A (en) * 1997-06-06 2000-05-23 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Method for decreasing the appetite in bulimic, overweight individuals

Also Published As

Publication number Publication date
EP1001760A1 (de) 2000-05-24
US6335021B1 (en) 2002-01-01
ITRM970365A0 (de) 1997-06-18
DE69828881T2 (de) 2006-01-19
PT1001760E (pt) 2005-04-29
KR20010013887A (ko) 2001-02-26
IT1291930B1 (it) 1999-01-21
AU7930498A (en) 1999-01-04
ITRM970365A1 (it) 1998-12-18
ES2236910T3 (es) 2005-07-16
DK1001760T3 (da) 2005-05-23
DE69828881D1 (de) 2005-03-10
CA2294589A1 (en) 1998-12-23
WO1998057629A1 (en) 1998-12-23
EP1001760B1 (de) 2005-02-02
JP2002505681A (ja) 2002-02-19

Similar Documents

Publication Publication Date Title
ATE288265T1 (de) Zusammensetzung zur linderung von störungen der stimmungslage bei gesunden individuen
NO972972L (no) Sammensetninger for behandling av dermatologiske forstyrrelser og metoder for deres anvendelse
DE69612012D1 (de) Verbundwerkstoff zur verwendung bei der herstellung des shuhwerks
DE69637021D1 (de) Zusammensetzungen zur Erzielung von Analgesie und zur Hemmung der Progression neuropathischer Schmerzerkrankungen
IT1284108B1 (it) Presidio chirurgico per il trattamento dell'enfisema polmonare
DE60133389D1 (de) Gabapentinanaloga für schlafstörungen
DE69718284D1 (de) Sprachsynthesesystem und Wellenform-Datenbank mit verringerter Redundanz
BG105515A (en) Substituted 2-phenylbenzimidazoles, the production thereof and their use
DE69626539D1 (de) topische Verwendung von Vitamin D zur Behandlung von Augenerkrankungen
ATE210447T1 (de) Verwendung von cck-b rezeptor antagonisten zur behandlung von schlafstörungen
ATE217191T1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
BR9914899A (pt) Uso de (r)-tofisopam opticamente puro para o tratamento e a prevenção de distúrbios de ansiedade e composição do mesmo
DE59709922D1 (de) Pflaster zur transdermalen anwendung von pergolid
DE69727674D1 (de) Zur herstellung von gebrannten mustern
DE50010234D1 (de) Verwendung von desoxypeganin zur behandlung von alzheimerischer demenz
ATE51229T1 (de) Oxa- und thiadiazolylderivate und ihre verwendung.
NO974569L (no) Benzamider for behandling av neurodegenerative forstyrrelser
DE59606616D1 (de) Dicarbonsäurederivate und ihre Verwendung zur Herstellung von Poly-o-hydroxyamiden oder Poly-o-mercaptoamiden
DE59609977D1 (de) Trapidil zur verwendung in der therapie von immunmodulatorisch beeinflussbaren krankheitsbildern
DE59711240D1 (de) Verwendung von flupirtin zur therapie und prophylaxe von myokardinfarkt, schockniere und schocklunge
BR9909868A (pt) Ascorbato de paroxetina
DE69121210D1 (de) Therapeutische verwendung des fibroblastenwachstumsfaktors
ATE297727T1 (de) Verwendung von anethol-dithiolethion zur vorbeugung und behandlung der sehnentoxizität
NO984430L (no) Anvendelse av en inhibitor av Na+/H+-utveksler for fremstilling av medikament for behandling av profylakser av sykdommer i sentralnervesystemet
LV11659A (lv) Sprotu konservu izgatavosanas panemiens

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1001760

Country of ref document: EP

REN Ceased due to non-payment of the annual fee